Home
 /
Papers
 /
Cancer Biology
 /
Regenerative cell turnover coupled to a tumor-hostile niche protects naked mole-rats from cancer
Preprint
Open access
V1
Top 1% · Validated by QED

Regenerative cell turnover coupled to a tumor-hostile niche protects naked mole-rats from cancer

Mikaela Behm, Pablo Baeza-Centurión, Sabrina Weser +27 more
February 2026
 ·
bioRxiv
 ·
DOI 
10.1101/2023.10.10.561212
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Cancer Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

This work overturns the assumption that high cellular turnover inevitably drives cancer, revealing that naked mole-rats neutralize malignancy through hybrid progenitors that dilute mutant clones and metabolically restricted fibroblasts that block tumor-permissive signaling.

QED claims analysis

Summary

Naked mole-rat skin maintains cancer resistance despite elevated mutational burden and high cellular turnover through a multi-layered tumor-suppressive strategy that couples an expanded pool of differentiation-committed hybrid progenitor cells with replication-coupled genome maintenance pathways, turnover-driven clonal dilution, and a metabolically constrained, non-inflammatory stromal microenvironment that collectively prevent malignant progression under chronic carcinogenic stress.

See full analysis
Main Claim 1 –

Naked mole-rat skin shows higher mutation burden and clone sizes

Supporting evidence

  • DMBA mutagenicity is equivalent in mouse and naked mole-rat fibroblasts
  • Cross-species antibody specificity validation supports reliable protein comparisons
Main Claim 2 –

Naked mole-rat interfollicular epidermis proliferates twice as fast

Main Claim 3 –

Naked mole-rats expand K14+/K10+ differentiation-committed hybrid progenitors

Supporting evidence

  • Hybrid progenitors buffer injury by preferential terminal differentiation
Main Claim 4 –

Genotoxic stress triggers replication-coupled DNA repair in naked mole-rats

Supporting evidence

  • Mice delaminate damaged cells; naked mole-rats retain basal damage
  • Apoptosis unchanged; mice upregulate necroptosis after genotoxic stress
  • PCNA induction and prolonged S-phase indicate replication-coupled repair
  • Low immune cellularity in naked mole-rats persists after DMBA
  • Naked mole-rats have fewer, less diverse T cells
  • Naked mole-rat T cells suppress TNF/NF-κB after DMBA
  • Mice activate inflammatory M2 macrophages; naked mole-rats expand dendritic cells
  • Naked mole-rat myeloid cells remain regulatory without inflammation

Abstract

Long-lived species suppress cancer despite accumulating somatic mutations throughout life, but how this is achieved in renewing tissues remains unclear. Here, we show that naked mole-rat skin uncouples high cellular turnover from cancer risk through coordinated epithelial and stromal mechanisms that constrain clonal outgrowth and suppress tumor-promoting inflammation. Despite elevated epidermal proliferation and mutational burden, naked mole-rat skin maintains tissue integrity through an expanded pool of early committed progenitor (hybrid) cells and replication-coupled genome maintenance pathways. Under chronic carcinogenic stress, undifferentiated basal cells replenish the hybrid progenitor pool. This dilutes initiated clones and permits only limited selective expansion of rare cancer gene–mutant clones. Depletion of the hybrid compartment shifts this protective state toward clonal expansion and inflammatory activation. These expanding clones are further constrained by a highly tumor-suppressive stromal microenvironment, driven by fibroblasts that adopt a metabolically restricted, non-inflammatory program. Together, our data uncover a multi-layered tumor-suppressive strategy that couples turnover-driven regeneration with an anti-permissive stromal niche to prevent malignant progression under mutagenic stress.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?